Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR

Stem Cell Rev Rep. 2021 Dec;17(6):2120-2123. doi: 10.1007/s12015-021-10251-6. Epub 2021 Aug 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19
  • B-Cell Maturation Antigen*
  • Cell Count
  • Humans
  • Lupus Erythematosus, Systemic* / drug therapy

Substances

  • Antigens, CD19
  • B-Cell Maturation Antigen